Shingles Vaccine

The shingles vaccine is a safe and effective way to prevent shingles, a common rash caused by the same virus that causes chickenpox. The vaccine is usually given to people over the age of 50 and those with weakened immune systems, and it is the best way to reduce the risk of developing the disease and its complications. The vaccine has been shown to reduce the risk of shingles by more than half; it can also reduce the severity and duration of symptoms if a person does develop shingles. The shingles vaccine has been introduced in many countries around the world and is recommended for adults aged 50 years and older and those with weakened immune systems. It is particularly important for those at higher risk for developing shingles and its associated complications, such as people with HIV/AIDS, cancer, or autoimmune diseases. It is important to note that the shingles vaccine does not prevent chickenpox, nor does it cure a person who already has shingles.

← Journal of Immunization

Related Articles

13 article(s) found
RETRACTED: Efficacy of BCG Vaccine and Role of Non Specific Sensitivity Due to Atypical Mycobacteria
Full-text HTML Download PDF Download XML
COVID-19 Vaccine Development: Insights, Prospects and Challenges
Full-text HTML Download PDF Download XML
Vaccine Hesitancy: A significant Challange
Full-text HTML Download PDF Download XML
Dynamics of Infections and Number of Vaccines Needed to Avoid Covid-19 in Europe
Full-text HTML Download PDF Download XML
Characterization of the Vaccine Abdala
Full-text HTML Download PDF Download XML
FDA Should Re-evaluate All mRNA Vaccines and Revoke Their Use Authorizations (The Short Version).
Full-text HTML Download PDF Download XML
Expression of Concern: Potential Risks and Unknown Effects of mRNA Vaccines on Population Health (6th Rev). Damages Are Being Materialized
Full-text HTML Download PDF Download XML
Anti-COVID19 Vaccine among Workers at the Local Health Authority of Rieti (Italy). Study on the Vaccine Efficacy and Seroprevalence Post-Vaccination
Full-text HTML Download PDF Download XML
Epidemio-Clinical Profile of Acute Diarrhea in Children From 0 To 5 Years and Prevalence of Rotavirus Before and After the Introduction of the Rotasiil Vaccine in the Democratic Republic of Congo.
Full-text HTML Download PDF Download XML
The Effects of Dairy Consumption on Vaccine Immune Response and Immunoglobulins: A Systematic Literature Review
Full-text HTML Download PDF Download XML
Predictors of COVID-19 Vaccine Hesitancy in North-Central Nigeria
Full-text HTML Download PDF Download XML
Predictors of COVID-19 Vaccine Uptake Among Healthcare Workers in Kiambu County, Kenya
Full-text HTML Download PDF Download XML
Retraction: Efficacy of BCG Vaccine and Role of Non Specific Sensitivity Due to Atypical Mycobacteria
Full-text HTML Download PDF Download XML